Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multiplexed Microsphere-Based Flow Cytometric Assay to Assess Strain Transcending Antibodies to Plasmodium vivax Duffy Binding Protein II Reveals an Efficient Tool to Identify Binding-Inhibitory Antibody Responders

Frontiers in Immunology(2021)10.3389/fimmu.2021.704653Source: DataRank Database

Multiplexed Microsphere-Based Flow Cytometric Assay to Assess Strain Transcending Antibodies to Plasmodium vivax Duffy Binding Protein II Reveals an Efficient Tool to Identify Binding-Inhibitory Antibody Responders is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 0.00)OA: goldTopics (38)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Fernanda Fortes de Araújo ORCID,Camilla Valente Pires ORCID,Andréa Teixeira‐Carvalho ORCID,Bárbara A. S. Lima,Leticia M. Torres‐Martínez ORCID

Live enrichment

PubMed:34675915 PMC:PMC8523986 OpenAlex:https://openalex.org/W3201730053

NIAID NIH HHS

Grant: R01 AI064478

National Institutes of Health

Grant: 5R01AI064478-09

Immunological characterization of the P. vivax DBP

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Office of Research Infrastructure Programs, National Institutes of Health

Fundação de Amparo à Pesquisa do Estado de Minas Gerais

FWCI

0.00

Citation Percentile

0.2%

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.704653/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.704653/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.704653/full

journalhttps://doi.org/10.3389/fimmu.2021.704653

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34675915

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchComplement system in diseasesBacteriophages and microbial interactions03 medical and health sciences0302 clinical medicine

MeSH Terms

Antibodies, ProtozoanAntigens, ProtozoanFlow CytometryHumansPlasmodium vivaxReceptors, Cell SurfaceProtozoan ProteinsMalaria, VivaxAntibodies, Neutralizing

Keywords

AntibodyMicrospherePlasmodium vivaxFlow cytometryStrain (injury)VirologyMolecular biologyBiologyChemistryImmunologyMalariaPlasmodium falciparumMultiplex AssayDuffy Binding ProteinInhibitory AntibodiesProtozoan ProteinsAntibodies, ProtozoanAntigens, ProtozoanReceptors, Cell SurfaceRC581-607Antibodies, NeutralizingMalaria, VivaxHumansImmunologic diseases. Allergy

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being